Last reviewed · How we verify

NCT05411939

Investigating the Impact of a Shared Decision-Making Tool

Completed NA Last updated 18 January 2024
What this trial tests

NA trial testing Shared Decision-Making Tool in Osteoarthritis, Knee in 105 participants. Completed in 20 September 2023.

Timeline
15 April 2023
Primary endpoint
20 September 2023
20 September 2023

Quick facts

Lead sponsorYale University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment105
Start date15 April 2023
Primary completion20 September 2023
Estimated completion20 September 2023
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Yale University

Who can join

Adults 45 to 65, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to learn more about how the use of a Shared Decision-Making Tool (SDMT) will impact a patient's decision-making to pursue treatment for knee osteoarthritis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. WITHDRAWN: The Impact of a Knee Osteoarthritis Clinician-Led Patient Specific Shared-Decision Making Tool in the Adult Reconstruction Clinical Setting: A Movement is Life Musculoskeletal Disparities Project
    Romero SJ, Rancu AL, Clemons TL, Dlott C, et al · · 2024 · DOI 10.21203/rs.3.rs-5618834/v1

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Yale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05411939.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing